Insider Transactions in Q4 2023 at Centene Corp (CNC)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2023
|
Kenneth A Burdick Director |
BUY
Grant, award, or other acquisition
|
Direct |
485
+0.13%
|
-
|
|
Dec 31
2023
|
Frederick H Eppinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
433
+0.13%
|
-
|
|
Dec 31
2023
|
Wayne S De Veydt Director |
BUY
Grant, award, or other acquisition
|
Direct |
537
+5.1%
|
-
|
|
Dec 31
2023
|
Christopher J Coughlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
502
+2.21%
|
-
|
|
Dec 31
2023
|
Theodore R. Samuels Ii Director |
BUY
Grant, award, or other acquisition
|
Direct |
433
+4.29%
|
-
|
|
Dec 15
2023
|
Sarah London Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,119
-0.92%
|
$383,925
$75.51 P/Share
|
|
Dec 15
2023
|
Christopher Koster Secretary & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,889
-2.78%
|
$366,675
$75.51 P/Share
|
|
Dec 15
2023
|
Andrew Lynn Asher Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,548
-1.12%
|
$341,100
$75.51 P/Share
|
|
Dec 15
2023
|
David P Thomas CEO, Markets and Medicaid |
SELL
Payment of exercise price or tax liability
|
Direct |
2,433
-1.8%
|
$182,475
$75.51 P/Share
|